These results demonstrated that the UAIscore could serve as an excellent and independent biomarker, and its predictive capability could be further enhanced through combination with ctDNA, tTMB, and PD‐L1 as a multi‐omic model for immunotherapy in urothelial carcinoma. The gene discussed is CD274; the disease is urothelial carcinoma.